Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DESIRABLE: Denosumab in Rheumatoid Arthritis
NCT01973569Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Oct 2013
- Primary completion
- Dec 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab in rheumatoid arthritis (RA), sponsored by Daiichi Sankyo Co., Ltd.. Started Oct 2013; status: completed.
02
Drugs
denosumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01973569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01973569.